- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/94 - Nitrogen atoms
Patent holdings for IPC class C07D 239/94
Total number of patents in this class: 721
10-year publication summary
|
54
|
46
|
41
|
46
|
54
|
30
|
64
|
50
|
36
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19517 |
17 |
| Araxes Pharma LLC | 89 |
17 |
| Boehringer Ingelheim International GmbH | 4754 |
15 |
| NATCO Pharma Limited | 205 |
13 |
| Gilead Sciences, Inc. | 1951 |
10 |
| Bristol-myers Squibb Company | 4863 |
8 |
| Genentech, Inc. | 3869 |
8 |
| Janssen Pharmaceutica N.V. | 3612 |
7 |
| Chiesi Farmaceutici S.p.A. | 958 |
7 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 177 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
7 |
| Merck Patent GmbH | 5842 |
6 |
| The Trustees of Columbia University in the City of New York | 3524 |
6 |
| Northwestern University | 3276 |
6 |
| Asana Biosciences, LLC | 43 |
6 |
| Council of Scientific & Industrial Research | 1409 |
6 |
| Evotec International GmbH | 83 |
6 |
| Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. | 13 |
6 |
| The Scripps Research Institute | 1353 |
6 |
| Shanghai Allist Pharmaceuticals, Inc. | 24 |
6 |
| Other owners | 551 |